$LAB
STANDARD BIOTOOLS INC.

2013 Q2 Form 10-Q Financial Statement

#000119312513210608 Filed on May 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $17.48M $14.54M $10.95M
YoY Change 35.0% 32.8% 25.85%
Cost Of Revenue $4.876M $4.259M $3.546M
YoY Change 24.2% 20.11% 21.86%
Gross Profit $12.60M $10.28M $7.399M
YoY Change 39.7% 38.88% 28.01%
Gross Profit Margin 72.11% 70.7% 67.6%
Selling, General & Admin $11.60M $11.15M $9.403M
YoY Change 23.1% 18.54% 26.38%
% of Gross Profit 92.01% 108.47% 127.08%
Research & Development $4.997M $4.197M $4.279M
YoY Change 25.33% -1.92% 32.89%
% of Gross Profit 39.65% 40.84% 57.83%
Depreciation & Amortization $610.0K $580.0K $500.0K
YoY Change 221.05% 16.0% 92.31%
% of Gross Profit 4.84% 5.64% 6.76%
Operating Expenses $16.59M $15.34M $13.68M
YoY Change 23.76% 12.14% 28.23%
Operating Profit -$3.990M -$5.067M -$6.283M
YoY Change -9.03% -19.35% 28.49%
Interest Expense $2.000K $10.00K $307.0K
YoY Change -99.01% -96.74% -112.38%
% of Operating Profit
Other Income/Expense, Net -$39.00K -$213.0K -$61.00K
YoY Change -533.33% 249.18% -187.14%
Pretax Income -$4.031M -$3.513M -$6.651M
YoY Change -11.97% -47.18% -8.77%
Income Tax $15.00K $38.00K $39.00K
% Of Pretax Income
Net Earnings -$4.046M -$3.551M -$6.690M
YoY Change -11.66% -46.92% -61.19%
Net Earnings / Revenue -23.15% -24.43% -61.12%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.16 -$0.14 -$0.33
COMMON SHARES
Basic Shares Outstanding 25.42M shares 25.27M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.40M $79.60M $38.90M
YoY Change 59.37% 104.63% -49.94%
Cash & Equivalents $32.29M $61.82M $8.496M
Short-Term Investments $28.10M $17.80M $30.40M
Other Short-Term Assets $2.000M $1.600M $1.600M
YoY Change 25.0% 0.0% 60.0%
Inventory $7.233M $7.371M $6.400M
Prepaid Expenses
Receivables $10.84M $10.06M $9.800M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $80.54M $98.56M $56.70M
YoY Change 44.6% 73.82% -37.56%
LONG-TERM ASSETS
Property, Plant & Equipment $4.919M $5.019M $3.600M
YoY Change 22.98% 39.42% 56.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $23.10M $7.300M $6.100M
YoY Change 2210.0% 19.67% 369.23%
Other Assets $3.431M $2.363M $4.400M
YoY Change -18.31% -46.3% 1366.67%
Total Long-Term Assets $31.42M $14.68M $14.00M
YoY Change 241.55% 4.86% 258.97%
TOTAL ASSETS
Total Short-Term Assets $80.54M $98.56M $56.70M
Total Long-Term Assets $31.42M $14.68M $14.00M
Total Assets $112.0M $113.2M $70.70M
YoY Change 72.52% 60.17% -25.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.997M $3.214M $4.100M
YoY Change -39.48% -21.61% -12.77%
Accrued Expenses $4.641M $4.149M $5.800M
YoY Change -7.18% -28.47% 34.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $6.300M
YoY Change -21.25%
Total Short-Term Liabilities $11.63M $11.54M $17.70M
YoY Change -21.45% -34.82% -4.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $310.0K $205.0K $1.000M
YoY Change -74.17% -79.5% -9.09%
Total Long-Term Liabilities $310.0K $205.0K $1.000M
YoY Change -74.17% -79.5% -86.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.63M $11.54M $17.70M
Total Long-Term Liabilities $310.0K $205.0K $1.000M
Total Liabilities $13.58M $13.11M $18.80M
YoY Change -15.13% -30.25% -27.69%
SHAREHOLDERS EQUITY
Retained Earnings -$248.4M -$244.4M
YoY Change
Common Stock $25.00K $25.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $98.39M $100.1M $51.90M
YoY Change
Total Liabilities & Shareholders Equity $112.0M $113.2M $70.70M
YoY Change 72.52% 60.17% -25.34%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$4.046M -$3.551M -$6.690M
YoY Change -11.66% -46.92% -61.19%
Depreciation, Depletion And Amortization $610.0K $580.0K $500.0K
YoY Change 221.05% 16.0% 92.31%
Cash From Operating Activities -$2.640M -$884.0K -$6.643M
YoY Change -34.0% -86.69% 440.08%
INVESTING ACTIVITIES
Capital Expenditures $1.360M $698.0K $397.0K
YoY Change 61.9% 75.82% 80.45%
Acquisitions $0.00
YoY Change
Other Investing Activities -$26.15M $3.090M $4.970M
YoY Change -451.95% -37.83% -122.73%
Cash From Investing Activities -$27.52M $2.395M $4.570M
YoY Change -517.6% -47.59% -120.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $3.818M
YoY Change -100.0%
Cash From Financing Activities 650.0K $1.767M -3.038M
YoY Change -157.52% -158.16% -104.14%
NET CHANGE
Cash From Operating Activities -2.640M -$884.0K -6.643M
Cash From Investing Activities -27.52M $2.395M 4.570M
Cash From Financing Activities 650.0K $1.767M -3.038M
Net Change In Cash -29.51M $3.278M -5.111M
YoY Change -2121.23% -164.14% -110.2%
FREE CASH FLOW
Cash From Operating Activities -$2.640M -$884.0K -$6.643M
Capital Expenditures $1.360M $698.0K $397.0K
Free Cash Flow -$4.000M -$1.582M -$7.040M
YoY Change -17.36% -77.53% 385.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25420613 shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8496000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1560000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
17800000
CY2013Q1 us-gaap Loss Contingency Range Of Possible Loss Maximum
LossContingencyRangeOfPossibleLossMaximum
1000000
CY2013Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1572000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2363000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
100124000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1812000
CY2013Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2445000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
19300000
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2246000
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25399000 shares
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1510000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1169000
CY2013Q1 us-gaap Liabilities
Liabilities
13113000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3214000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
598000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1928000
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
205000
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2356000
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q1 us-gaap Long Term Investments
LongTermInvestments
7298000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-244373000
CY2013Q1 us-gaap Assets
Assets
113237000
CY2013Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
18000
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10056000
CY2013Q1 us-gaap Inventory Net
InventoryNet
7371000
CY2013Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26575000
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113237000
CY2013Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1504000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61815000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25399000 shares
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-772000
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4149000
CY2013Q1 us-gaap Cash
Cash
60293000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11537000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
441000
CY2013Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3354000
CY2013Q1 us-gaap Short Term Investments
ShortTermInvestments
17755000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
25000
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1371000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
98557000
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15927000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5019000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
345244000
CY2013Q1 fldm Operating Leases Future Minimum Payments Due After Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueAfterFiveYearsAndThereafter
8482000
CY2013Q1 fldm Expected Milestone Receivable
ExpectedMilestoneReceivable
3200000
CY2010Q4 us-gaap Debt Instrument Basis Spread On Variable Rate
DebtInstrumentBasisSpreadOnVariableRate
0.0100 pure
CY2010Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
7000000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13553000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1131000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1369000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3881000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
100657000
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2846000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2877000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25115000 shares
CY2012Q4 us-gaap Liabilities
Liabilities
13075000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2555000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1886000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
237000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
3666000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-240821000
CY2012Q4 us-gaap Assets
Assets
113732000
CY2012Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
17000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12900000
CY2012Q4 us-gaap Inventory Net
InventoryNet
7169000
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26596000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113732000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1550000
CY2012Q4 us-gaap Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
1300000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58649000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25115000 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-769000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4279000
CY2012Q4 us-gaap Cash
Cash
57082000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11597000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
448000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2954000
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
21362000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
25000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1241000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
101211000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4974000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
342222000
CY2012Q2 fldm Debt Instrument Additional Payment Principal
DebtInstrumentAdditionalPaymentPrincipal
1900000
CY2011Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
600000
CY2012Q1 fldm Debt Instrument Additional Payment Principal
DebtInstrumentAdditionalPaymentPrincipal
2300000
CY2013Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1800000
CY2013Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3100000
CY2010Q4 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year.
CY2010Q4 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0425 pure
CY2010Q4 fldm Term Of Contractual Agreement Include Line Of Credit Facility
TermOfContractualAgreementIncludeLineOfCreditFacility
P2Y
CY2012 fldm Line Of Credit Facility Extension Length
LineOfCreditFacilityExtensionLength
P2Y
CY2013Q1 dei Trading Symbol
TradingSymbol
FLDM
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
FLUIDIGM CORP
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001162194
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
19602000
CY2013Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Reclassifications</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or net decrease in cash and cash equivalents.</font></p> </div>
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-939000
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7414000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5067000
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2013Q1 us-gaap Revenue From Grants
RevenueFromGrants
165000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
14254000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1128000
CY2013Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-213000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3555000
CY2013Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
10200000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1255000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2013Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1777000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1767000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-884000
CY2013Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3117000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2395000
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
319000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
698000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3166000
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
397000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1093000 shares
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2933000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3513000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000
CY2013Q1 us-gaap Licenses Revenue
LicensesRevenue
116000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4197000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1767000
CY2013Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
439000
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2013Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
7390000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4259000
CY2013Q1 us-gaap Revenues
Revenues
14535000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1300000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25242000 shares
CY2013Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
584000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-3551000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11146000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-112000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6283000
CY2013Q1 us-gaap Interest Expense
InterestExpense
10000
CY2013Q1 fldm Date Of Incorporation Of Company
DateOfIncorporationOfCompany
1999-05
CY2013Q1 fldm Date Of Reincorporation Of Company
DateOfReincorporationOfCompany
2007-07
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
17228000
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
507000
CY2012Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19393000
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-48000
CY2012Q1 us-gaap Revenue From Grants
RevenueFromGrants
166000
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10756000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-189000
CY2012Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3818000
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6713000
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
935000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2012Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
780000
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6643000
CY2012Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4570000
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-465000
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
397000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5057000
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
233000
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
577000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6651000
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23000
CY2012Q1 us-gaap Licenses Revenue
LicensesRevenue
23000
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4279000
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3038000
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
474000
CY2012Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
24360000
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3546000
CY2012Q1 us-gaap Revenues
Revenues
10945000
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20394000 shares
CY2012Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
495000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-6690000
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9403000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39000
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
54000
CY2012Q1 us-gaap Interest Expense
InterestExpense
307000

Files In Submission

Name View Source Status
0001193125-13-210608-index-headers.html Edgar Link pending
0001193125-13-210608-index.html Edgar Link pending
0001193125-13-210608.txt Edgar Link pending
0001193125-13-210608-xbrl.zip Edgar Link pending
d514707d10q.htm Edgar Link pending
d514707dex1019a.htm Edgar Link pending
d514707dex311.htm Edgar Link pending
d514707dex312.htm Edgar Link pending
d514707dex321.htm Edgar Link pending
d514707dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
fldm-20130331.xml Edgar Link completed
fldm-20130331.xsd Edgar Link pending
fldm-20130331_cal.xml Edgar Link unprocessable
fldm-20130331_def.xml Edgar Link unprocessable
fldm-20130331_lab.xml Edgar Link unprocessable
fldm-20130331_pre.xml Edgar Link unprocessable
g514707g10w97.jpg Edgar Link pending
g514707g20q92.jpg Edgar Link pending
g514707g44i71.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending